Dogwood TherapeuticsDWTX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 15 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, up 2 from Q1 2026. 5 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($5.0M), Millennium Management ($550K) and Vanguard Capital Management LLC ($213K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $573K |
| Exits | 3 | $56K |
All 13F filers, Q1 2026 → Q2 2026: 393,475 shares bought and 184,069 shares sold, net +209,406 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Armistice Capital, LLC | 0.14% | Reduce -4.5% | 3,132,486 | $5.0M |
| Millennium Management | 0.00% | New | 341,814 | $550K |
| Vanguard Capital Management LLC | 0.00% | No change | 132,154 | $213K |
| Geode Capital Management, LLC | 0.00% | Add +11.2% | 88,298 | $142K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 62,736 | $101K |
| BlackRock, Inc. | 0.00% | Add +95053.3% | 28,546 | $46K |
| Northern Trust Corp. | 0.00% | No change | 23,779 | $38K |
| Citadel Advisors | 0.00% | New | 11,742 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -61.7% | 3,093 | $5K |
| Morgan Stanley | 0.00% | New | 2,222 | $4K |
| UBS Group AG | 0.00% | Reduce -73.8% | 1,860 | $3K |
| Jones Financial Companies LLLP | 0.00% | New | 160 | $264 |
| Barclays PLC | 0.00% | New | 157 | $253 |
| Activest Wealth Management | 0.00% | No change | 120 | $193 |
| Group One Trading LLC | 0.00% | No change | 9 | $14 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.